Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Kasabach-Merritt syndrome (KMS) refers to the combination of large neonatal vascular tumors and thrombocytopenic coagulopathy. However, a standard treatment regimen for KMS has not yet been established. We report a case of a 6-week-old male infant with life-threatening KMS who was successfully treated with transarterial embolization and corticosteroids. One week after initiating the corticosteroid treatment, his platelet counts recovered, and the lesion growth halted. The approach with corticosteroid therapy resulted in an excellent response that was maintained long enough for us to perform transarterial embolization therapy. The combination of transarterial embolization and corticosteroid therapy should be considered as an option for Kasabach-Merritt syndrome. Copyright © 2013 Elsevier Inc. All rights reserved.

Citation

Shao-yi Zhou, Hai-bo Li, Yue-ming Mao, Pei-ying Liu, Jing Zhang. Successful treatment of Kasabach-Merritt syndrome with transarterial embolization and corticosteroids. Journal of pediatric surgery. 2013 Mar;48(3):673-6

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23480932

View Full Text